T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives
Many studies have reported that patients with psychosis, even before drug treatment, have mildly raised levels of blood cytokines relative to healthy controls. In contrast, there is a remarkable scarcity of studies investigating the cellular basis of immune function and cytokine changes in psychosis...
Main Authors: | Fabiana Corsi-Zuelli, Bill Deakin, Mikhael Haruo Fernandes de Lima, Omar Qureshi, Nicholas M. Barnes, Rachel Upthegrove, Paulo Louzada-Junior, Cristina Marta Del-Ben |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354621001332 |
Similar Items
-
Interleukin-10 Producing Regulatory B Cells Transformed CD4+CD25− Into Tregs and Enhanced Regulatory T Cells Function in Human Leprosy
by: Mohd. Tarique, et al.
Published: (2018-07-01) -
Expression of the T regulatory cell transcription factor FoxP3 in peri-implantation phase endometrium in infertile women with endometriosis
by: Chen Shufang, et al.
Published: (2012-04-01) -
CD4+FoxP3+ regulatory T-cells in human systemic lupus erythematosus
by: Jau-Ling Suen, et al.
Published: (2012-09-01) -
Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity
by: R. Gerli, et al.
Published: (2012-12-01) -
The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma – an immunohistochemical study
by: Satu Salmi, et al.
Published: (2021-05-01)